Getinge's big medtech news was the $680 million deal for soft tissue reinforcement technology developer Atrium Medical by subsidiary Maquet Cardiovascular. Getinge said demand for its medical devices in emerging markets not improving as much as expected, while the recovery in developed markets was slow. U.S. competitors include medical technology groups Stryker, Medtronic, and Steris.
|Key Personnel: Mattias Perjos, president & CEO; Reinhard Mayer, CFO; Frédéric Pette, acting president, surgical workflows; Jens Viebke president, acute care therapies; Joacim Lindoff, president, patient & post-acute care; Carsten Blecker, president, EMEA; Raoul Quintero, president, Americas; Lena Hagman, EVP, quality, regulatory & compliance; Jeanette Hedén Carlsson, EVP, communications & brand management; Magnus Lundbäck, EVP, HR & sustainability; Markus Medart, acting president, supply chain;|
Theres Svenssons gata 7